GlassScriptPhysician profile
Donald Gary Kolva
NPI 1396847968
$27,538.58
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $1,029 · 2021: $283 · 2022: $15.40.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $11,819.66 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $7,499.71 | 2019 | |
| Acorda Therapeutics, INC | $7,080.64 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $201.77 | 2019-2021 | |
| Genzyme Corporation | $189.14 | 2019-2021 | |
| Genentech USA, INC. | $162.53 | 2019 | |
| Mallinckrodt Enterprises LLC | $124.74 | 2019 | |
| Emd Serono, INC. | $118.08 | 2019 | |
| Lilly USA, LLC | $54.20 | 2019 | |
| Promius Pharma LLC | $45.24 | 2019 | |
| Alexion Pharmaceuticals, INC. | $43.48 | 2019 | |
| Assertio Therapeutics, INC. | $28.67 | 2019 | |
| Supernus Pharmaceuticals, INC. | $27.47 | 2019 | |
| Bausch Health US, LLC | $24.39 | 2019 | |
| Acadia Pharmaceuticals INC | $23.46 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $19.77 | 2019 | |
| Amgen INC. | $18.27 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.95 | 2019 | |
| Allergan, INC. | $15.40 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.97 | 2019 | |
| Pfizer INC. | $11.04 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Kolva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.